| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $70.0M | — |
| R&D Expense | $33.6M | -34.6% |
| SG&A Expense | $16.6M | -39.7% |
| Operating Income | $12.5M | +115.9% |
| Income Tax | $0 | — |
| Net Income | $22.4M | +132.1% |
| EPS (Basic) | $0.39 | +130.7% |
| EPS (Diluted) | $0.39 | +130.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.0M | -42.4% |
| Current Assets | $132.4M | +30.9% |
| Total Assets | $143.0M | +16.6% |
| Current Liabilities | $15.7M | -23.5% |
| Total Liabilities | $30.8M | -21.7% |
| Stockholders' Equity | $112.2M | +34.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $29.6M | +147.5% |
| Investing Cash Flow | -$44.9M | -364.6% |
| Financing Cash Flow | -$146K | -100.6% |